Annual FCF
-$17.30 M
+$1.87 M+9.76%
31 December 2023
Summary:
Vaccinex annual free cash flow is currently -$17.30 million, with the most recent change of +$1.87 million (+9.76%) on 31 December 2023. During the last 3 years, it has risen by +$8.03 million (+31.70%). VCNX annual FCF is now at all-time high.VCNX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$3.21 M
+$1.21 M+27.41%
30 September 2024
Summary:
Vaccinex quarterly free cash flow is currently -$3.21 million, with the most recent change of +$1.21 million (+27.41%) on 30 September 2024. Over the past year, it has increased by +$377.00 thousand (+10.50%). VCNX quarterly FCF is now -3.28% below its all-time high of -$3.11 million, reached on 30 September 2023.VCNX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$15.87 M
-$102.00 K-0.65%
30 September 2024
Summary:
Vaccinex TTM free cash flow is currently -$15.87 million, with the most recent change of -$102.00 thousand (-0.65%) on 30 September 2024. Over the past year, it has increased by +$1.43 million (+8.28%). VCNX TTM FCF is now -242.43% below its all-time high of -$4.63 million, reached on 31 March 2017.VCNX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VCNX Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +10.5% | +8.3% |
| 3 y3 years | +31.7% | +37.5% | +37.4% |
| 5 y5 years | +43.8% | +44.6% | +48.5% |
VCNX Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +31.7% | -3.3% | +41.6% | -0.7% | +37.4% |
| 5 y | 5 years | at high | +43.8% | -3.3% | +65.6% | -0.7% | +48.5% |
| alltime | all time | at high | +43.8% | -3.3% | +69.4% | -242.4% | +51.5% |
Vaccinex Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$3.21 M(-27.4%) | -$15.87 M(+0.6%) |
| June 2024 | - | -$4.43 M(-4.4%) | -$15.77 M(-6.4%) |
| Mar 2024 | - | -$4.63 M(+29.0%) | -$16.84 M(-2.6%) |
| Dec 2023 | -$17.30 M(-9.8%) | -$3.59 M(+15.4%) | -$17.30 M(-5.5%) |
| Sept 2023 | - | -$3.11 M(-43.5%) | -$18.31 M(-5.6%) |
| June 2023 | - | -$5.51 M(+8.2%) | -$19.39 M(+0.6%) |
| Mar 2023 | - | -$5.09 M(+10.7%) | -$19.27 M(+0.5%) |
| Dec 2022 | -$19.17 M(-24.3%) | -$4.60 M(+9.6%) | -$19.17 M(-2.8%) |
| Sept 2022 | - | -$4.20 M(-22.1%) | -$19.72 M(-8.7%) |
| June 2022 | - | -$5.38 M(+7.8%) | -$21.59 M(-7.0%) |
| Mar 2022 | - | -$5.00 M(-2.9%) | -$23.21 M(-8.4%) |
| Dec 2021 | -$25.33 M(-12.5%) | -$5.14 M(-15.3%) | -$25.33 M(-4.7%) |
| Sept 2021 | - | -$6.07 M(-13.3%) | -$26.57 M(-11.0%) |
| June 2021 | - | -$7.00 M(-1.5%) | -$29.84 M(+5.5%) |
| Mar 2021 | - | -$7.11 M(+11.5%) | -$28.29 M(-2.2%) |
| Dec 2020 | -$28.94 M | -$6.38 M(-31.7%) | -$28.94 M(+2.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | -$9.34 M(+71.5%) | -$28.36 M(-3.9%) |
| June 2020 | - | -$5.45 M(-29.8%) | -$29.52 M(-1.9%) |
| Mar 2020 | - | -$7.76 M(+33.8%) | -$30.08 M(-2.3%) |
| Dec 2019 | -$30.79 M(+20.7%) | -$5.80 M(-44.7%) | -$30.79 M(-5.9%) |
| Sept 2019 | - | -$10.50 M(+74.6%) | -$32.72 M(+11.1%) |
| June 2019 | - | -$6.01 M(-29.1%) | -$29.44 M(+2.3%) |
| Mar 2019 | - | -$8.48 M(+9.7%) | -$28.77 M(+12.8%) |
| Dec 2018 | -$25.51 M(+18.9%) | -$7.73 M(+6.9%) | -$25.51 M(+6.1%) |
| Sept 2018 | - | -$7.22 M(+35.1%) | -$24.04 M(+11.5%) |
| June 2018 | - | -$5.35 M(+2.6%) | -$21.55 M(-2.2%) |
| Mar 2018 | - | -$5.21 M(-16.6%) | -$22.03 M(+2.7%) |
| Dec 2017 | -$21.45 M(+4.6%) | -$6.25 M(+31.9%) | -$21.45 M(+41.1%) |
| Sept 2017 | - | -$4.74 M(-18.7%) | -$15.21 M(+45.3%) |
| June 2017 | - | -$5.83 M(+25.8%) | -$10.46 M(+125.8%) |
| Mar 2017 | - | -$4.63 M | -$4.63 M |
| Dec 2016 | -$20.51 M | - | - |
FAQ
- What is Vaccinex annual free cash flow?
- What is the all time high annual FCF for Vaccinex?
- What is Vaccinex quarterly free cash flow?
- What is the all time high quarterly FCF for Vaccinex?
- What is Vaccinex quarterly FCF year-on-year change?
- What is Vaccinex TTM free cash flow?
- What is the all time high TTM FCF for Vaccinex?
- What is Vaccinex TTM FCF year-on-year change?
What is Vaccinex annual free cash flow?
The current annual FCF of VCNX is -$17.30 M
What is the all time high annual FCF for Vaccinex?
Vaccinex all-time high annual free cash flow is -$17.30 M
What is Vaccinex quarterly free cash flow?
The current quarterly FCF of VCNX is -$3.21 M
What is the all time high quarterly FCF for Vaccinex?
Vaccinex all-time high quarterly free cash flow is -$3.11 M
What is Vaccinex quarterly FCF year-on-year change?
Over the past year, VCNX quarterly free cash flow has changed by +$377.00 K (+10.50%)
What is Vaccinex TTM free cash flow?
The current TTM FCF of VCNX is -$15.87 M
What is the all time high TTM FCF for Vaccinex?
Vaccinex all-time high TTM free cash flow is -$4.63 M
What is Vaccinex TTM FCF year-on-year change?
Over the past year, VCNX TTM free cash flow has changed by +$1.43 M (+8.28%)